Assessment of serum ɛN-carboxymethyllysine and soluble receptor of advanced glycation end product levels among type 2 diabetes mellitus patients with and without acute coronary syndrome

Journal Title: International Journal of Medical Science and Public Health - Year 2018, Vol 7, Issue 11

Abstract

Background: One of the most predominant macrovascular complications of type 2 diabetes mellitus (T2DM) is acute coronary syndrome (ACS). Advanced glycation end products (AGEs) play an important role in the development and progression of ACS in T2DM patients. The soluble receptor of AGEs (sRAGE) decoys the effect of AGEs by binding with them. Objectives: The objectives of the study were to measure serum ɛN-carboxymethyllysine (CML) and sRAGE levels among T2DM with and without ACS and to find out whether serum CML and sRAGE could be used to predict the risk of ACS among T2DM patients. Materials and Methods: A total of 37 T2DM patients with ACS were selected as cases and 37 T2DM as controls. Routine biochemical parameters were carried out on autoanalyzer and serum CML and sRAGE were estimated by ELISA. The data were recorded and analyzed on SPSS system and were compared by Student’s t-test or Mann–Whitney test. Results: Serum CML level and CML/sRAGE ratio were significantly increased in the cases as compared to control. Correlation analyses showed that serum CML concentration and serum CML/sRAGE ratio were positively correlated with weight, waist circumference, body mass index and serum urea, and very low-density lipoprotein-cholesterol. Multivariate regression (Binary logistics) analysis after adjusted for waist circumference, weight, BMI, and systolic blood pressure showed that serum CML was significantly associated with ACS risk among T2DM patients. Receiver operating characteristic curve depicted that high CML level (>31.83 ng/ml) and CML/sRAGE ratio (>15.48) were associated with greatest risk of ACS among type 2 DM patients. Conclusion: T2DM patients with high serum CML concentration and CML/sRAGE ratio were at risk of ACS independent of other cardiovascular risks.

Authors and Affiliations

Shanija S, Prashant Shankarrao Adole, Kolar Vishwanath Vinod, Rama Prakasha Saya

Keywords

Related Articles

Awareness and practice of sex determination among married women of Ahmedabad district: a cross-sectional study

Background: Declining sex ratio is an issue of grave concern in India. A preference for boys cuts across caste and class lines and results in discrimination against girls even before they are born. Long before medica...

A hospital-based study of prevalence of thyroid dysfunction in Srinagar, Jammu and Kashmir state of India

Background: Signi fi cant incidence of thyroid dysfunction, especially hypothyroidism, has been reported in Kashmir Valley of India. There is a paucity of studies that assessed the presence of thyroid dysfunction in...

Prevalence of metabolic syndrome in higher socioeconomic class of Ahmedabad, Gujarat, India

Background: The metabolic syndrome (MetS) is a highly complex multifactorial endocrine disorder, which includes ectopic fat accumulation, impaired insulin sensitivity, and increased systemic inflammation. Globally, a...

Heart Rate variability in females with chronic somatic pain

Background: Various disease processes are associated with an altered symapatho-vagal activity which reflects the autonomic balance. Altered ANS activity is reported in patients suffering from chronic pain by various work...

Reporting of core and optional indicators of infant and young child feeding practices using standardized WHO formats from a rural population of Jammu region

Background: Adequate nutrition during infancy and early childhood are critical for the overall development of a child. Infant and young child feeding (IYCF) practices have direct bearing on nutritional status of children...

Download PDF file
  • EP ID EP489579
  • DOI 10.5455/ijmsph.2018.0721728072018
  • Views 70
  • Downloads 0

How To Cite

Shanija S, Prashant Shankarrao Adole, Kolar Vishwanath Vinod, Rama Prakasha Saya (2018). Assessment of serum ɛN-carboxymethyllysine and soluble receptor of advanced glycation end product levels among type 2 diabetes mellitus patients with and without acute coronary syndrome. International Journal of Medical Science and Public Health, 7(11), 879-884. https://europub.co.uk/articles/-A-489579